Your browser doesn't support javascript.
loading
Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1.
Quixabeira, Dafne C A; Cervera-Carrascon, Victor; Santos, Joao M; Clubb, James H A; Kudling, Tatiana V; Basnet, Saru; Heiniö, Camilla; Grönberg-Vähä-Koskela, Susanna; Anttila, Marjukka; Havunen, Riikka; Kanerva, Anna; Hemminki, Akseli.
Afiliação
  • Quixabeira DCA; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Cervera-Carrascon V; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Santos JM; TILT Biotherapeutics, Helsinki, Finland.
  • Clubb JHA; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Kudling TV; TILT Biotherapeutics, Helsinki, Finland.
  • Basnet S; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Heiniö C; TILT Biotherapeutics, Helsinki, Finland.
  • Grönberg-Vähä-Koskela S; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Anttila M; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Havunen R; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Kanerva A; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Hemminki A; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
Oncoimmunology ; 11(1): 2028960, 2022.
Article em En | MEDLINE | ID: mdl-35083096

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Adenoviridae / Terapia Viral Oncolítica / Melanoma Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Adenoviridae / Terapia Viral Oncolítica / Melanoma Idioma: En Ano de publicação: 2022 Tipo de documento: Article